Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating activities
Net loss	$ (540,000)	$ (905,000)	$ (7,300,000)	$ 142,000	$ (2,266,000)	$ (7,243,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation					178,000	202,000
Depreciation and amortization					3,000	5,000
SurancePlus management fee income					(312,000)	(300,000)
Change in fair value of other investments	424,000		6,889,000		1,937,000	6,384,000	$ 8,945,000
Change in fair value of equity securities	28,000		115,000		188,000	34,000
Interest and gain on redemption of loan receivable					(41,000)
Change in operating assets and liabilities:
Accrued interest and dividend receivable						(13,000)
Premiums receivable					(388,000)	(1,183,000)
Due from related party						(15,000)
Deferred policy acquisition costs					(74,000)	(161,000)
Prepayment and other assets					24,000	52,000
Prepaid offering costs						133,000
Losses payable						(1,073,000)
Other liabilities Cat Re Tokenholders					(1,195,000)	311,000
Unearned premiums reserve					671,000	1,463,000
Accounts payable and other liabilities					27,000	48,000
Net cash used in operating activities					(1,248,000)	(1,356,000)
Investing activities
Purchase of property and equipment						(5,000)
Proceeds (funding) of loan receivable					141,000	(100,000)
Proceeds from sale of equity securities					307,000
Net cash provided by/ (used in) investing activities					448,000	(105,000)
Financing activities
Proceeds from issuance of ordinary shares					407,000
Partial redemption of notes payable to noteholders						(98,000)	(98,000)
Net proceeds from the issuance of Epsilon/ Delta Cat Re tokens					1,469,000	1,280,000
Net cash provided by financing activities					1,876,000	1,182,000
Cash and cash equivalents, and restricted cash and cash equivalents:
Net change during the period					1,076,000	(279,000)
Balance at beginning of period		$ 3,745,000		$ 3,928,000	3,745,000	3,928,000	3,928,000
Balance at end of period	$ 4,821,000		$ 3,649,000		4,821,000	3,649,000	$ 3,745,000
Non-cash investing activities
Right-of-use lease asset obtained in exchange for operating lease liabilities					$ 124,000